“With coronavirus cases climbing in the U.S., this is likely going to be a clear focus for quite some time,” declares the author of today’s article in regards to the biotech sector. They proceed to highlight three biotech penny stocks to watch as August gets underway: two COVID-related plays as well as “one of the few listed penny stocks to have a foot in the emerging psychedelics industry.” For more, CLICK HERE.